Home › Mild Cognitive Impairment › Washington
Mild Cognitive Impairment clinical trials in Washington
6 studies for Mild Cognitive Impairment are looking for participants at sites in Washington.
Cities in Washington
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- EvergreenHealth, Kirkland
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
- University of Washington, Harborview Medical Center, Seattle
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT04916210Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial
- University of Washington, Seattle
RecruitingPhase 2
Ages 55 to 89 · All sexes · Updated Jul 28, 2026 · NCT06601933Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
- University of Washington, Seattle
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jan 15, 2026 · NCT05677880Effect of High-Intensity Exercise to Attenuate Cognitive Function Limitations and Train Exercise Habits in Older People Living With HIV
- University of Washington, Seattle
RecruitingHealthy volunteers welcome
Ages 50 to 80 · All sexes · Updated Dec 8, 2025 · NCT06013579A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors
- University of Washington, Seattle
Recruiting
Ages 60 and older · All sexes · Updated Jul 20, 2025 · NCT06411561From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.